Medical Services (CE) (USOTC:MSITF)
Historical Stock Chart
From Aug 2019 to Aug 2024
![Click Here for more Medical Services (CE) Charts. Click Here for more Medical Services (CE) Charts.](/p.php?pid=staticchart&s=NO%5EMSITF&p=8&t=15)
EDMONTON, Alberta, June 14 /PRNewswire-FirstCall/ -- Medical Services International Inc. (OTC:MSITF) is pleased to announce that the demand for the VScan products has increased so much that we must increase our production capability. The Company is using profits from existing sales to begin buying additional equipment necessary to increase our production capability by 1.5 million kits by the end of the year. Completion of this expansion will give the Company overall capacity of 6.8 million as well as expanding the Research and Development facility in the Unites States. The Company has also begun looking for a facility to purchase in the United States that will house the R&D facility. In keeping with its policy of no bank debt, the company expects to be in a position to pay cash for the new facility. It is felt that owning our own facility will add flexibility to our ability to expand in the future.
About VScan
The VScan rapid test kit is a single use, disposable, accurate, cost effective, easy to use, test for the screening of HIV1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile, Syphilis and Prostate Cancer. The kits cannot be sold in Canada.
Medical Services International Inc. trades in the United States on the NQB Pink Sheets under the symbol "MSITF". For further information, please contact Robert Talbot at (780) 430 6363 or http://www.medicalservicesintl.com/ or http://www.minerva-biotech.com/.
NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies.
DATASOURCE: Medical Services International Inc.
CONTACT: Robert Talbot for Medical Services International Inc.,
+1-780-430-6363
Web site: http://www.medicalservicesintl.com/
http://www.minerva-biotech.com/